Evidence map›Paper›PMID 40032622›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Isoselenourea-Catalyzed Enantioselective Pyrazolo-Heterocycle Synthesis Enabled by Self-Correcting Amide and Ester Acylation.

Martha I Prindl, Matthew T Westwood, Alister S Goodfellow, Aidan P McKay, David B Cordes, Michael Bühl, Andrew D Smith

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Martha I PrindlEaStCHEM, School of Chemistry, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.
Matthew T WestwoodEaStCHEM, School of Chemistry, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.
Alister S GoodfellowEaStCHEM, School of Chemistry, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.
Aidan P McKayEaStCHEM, School of Chemistry, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.
David B CordesEaStCHEM, School of Chemistry, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.
Michael BühlEaStCHEM, School of Chemistry, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.
Andrew D SmithEaStCHEM, School of Chemistry, University of St Andrews, St Andrews, Fife, KY16 9ST, UK.

Funding

EaSI-CAT centre for Doctoral TrainingEngineering and Physical Sciences Research Council EP/W007517
6 · The paper itself

Abstract

Pyrazole heterocycles are prevalent in a wide range of medicinal and agrochemical compounds, and as such, the development of methods for their enantioselective incorporation into molecular scaffolds is highly desirable. This manuscript describes the effective formation of fused pyrazolo-pyridones and -pyranones in high enantioselectivity (up to >99:1 er) via an isoselenourea (HyperSe) catalyzed enantioselective [3 + 3]-Michael addition-cyclization process using readily available pyrazolylsulfonamides or pyrazolones as pronucleophiles and α,β-unsaturated anhydrides as starting materials. Mechanistic analysis indicates an unusual self-correcting reaction pathway involving preferential [1,2]-addition of the pronucleophile to initially generate an intermediate amide or ester that can be intercepted by isoselenourea acylation, leading to productive formation of the fused heterocyclic products with high enantiocontrol. The scope and limitations of this process are developed across a range of examples, with insight into the factors leading to the observed enantioselectivity provided by density functional theory (DFT) analysis.

Indexed as

Enantioselective Michael additionIsoselenoureaPyrazoleSelf‐correcting amide acylation

Identifiers

PMID40032622
PMCPMC12051791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.